Relates to the use of artificial intelligence by insurers and clinical peer reviewers for utilization review; establishes additional notice requirements for adverse determinations.

Legislation addressing the use of artificial intelligence by insurers and clinical peer reviewers in utilization review decisions, establishing additional notice requirements when adverse determinations are made. It aims to increase transparency for patients affected by AI-assisted insurance review.